메뉴 건너뛰기




Volumn 9, Issue 9, 1998, Pages 765-772

Effect of etoposide on the pharmacokinetics of methotrexate in vivo

Author keywords

Brain tumor; Children; Etoposide; Methotrexate; Pharmacokinetics

Indexed keywords

ANTINEOPLASTIC ALKALOID; ETOPOSIDE; FOLIC ACID ANTAGONIST; METHOTREXATE;

EID: 0031790654     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199810000-00004     Document Type: Article
Times cited : (2)

References (22)
  • 1
    • 0028075793 scopus 로고
    • Pharmacokinetics of dibromodulcitol in children with brain tumor
    • Paál K, Schuler D, Csáki Cs, et al. Pharmacokinetics of dibromodulcitol in children with brain tumor. Anti-Cancer Drugs 1994; 5: 539-47.
    • (1994) Anti-Cancer Drugs , vol.5 , pp. 539-547
    • Paál, K.1    Schuler, D.2    Csáki, Cs.3
  • 2
    • 15144347353 scopus 로고
    • Pre- and postoperative chemotherapy in the multimodality treatment of brain tumors in children
    • Somlo P, Borsi JD, Kisban J, et al. Pre- and postoperative chemotherapy in the multimodality treatment of brain tumors in children. Med Pediatr Oncol 1991; 19: 407.
    • (1991) Med Pediatr Oncol , vol.19 , pp. 407
    • Somlo, P.1    Borsi, J.D.2    Kisban, J.3
  • 3
    • 15144361101 scopus 로고
    • Treatment of pediatric brain tumor patients with a multidrug chemotherapy-radiotherapy protocol containing dibromodulcitol
    • Ferencz T, Borsi JD, Paraicz E, et al. Treatment of pediatric brain tumor patients with a multidrug chemotherapy-radiotherapy protocol containing dibromodulcitol. Med Pediatr Oncol 1994; 23: 215.
    • (1994) Med Pediatr Oncol , vol.23 , pp. 215
    • Ferencz, T.1    Borsi, J.D.2    Paraicz, E.3
  • 4
    • 15144351566 scopus 로고
    • Combination chemotherapy containing dibromodulcitol with craniospinal irradiation in the treatment of childhood central nervous system malignancies
    • Ferencz T, Csáki Cs, Paál K, et al. Combination chemotherapy containing dibromodulcitol with craniospinal irradiation in the treatment of childhood central nervous system malignancies. Med Pediatr Oncol 1995; 25: 304.
    • (1995) Med Pediatr Oncol , vol.25 , pp. 304
    • Ferencz, T.1    Csáki, Cs.2    Paál, K.3
  • 5
    • 15144345668 scopus 로고    scopus 로고
    • Combined adjuvant chemotherapy in malignant pediatric brain tumors - Preliminary results
    • Ferencz T, Csaki C, Paal Ch, et al. Combined adjuvant chemotherapy in malignant pediatric brain tumors - preliminary results. Med Pediatr Oncol 1997; 29: 416.
    • (1997) Med Pediatr Oncol , vol.29 , pp. 416
    • Ferencz, T.1    Csaki, C.2    Paal, Ch.3
  • 7
    • 0028149207 scopus 로고
    • High performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid
    • Belz S, Frickel C, Wolfrom C. High performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid. J Chromatogr 1994; 661: 109-18.
    • (1994) J Chromatogr , vol.661 , pp. 109-118
    • Belz, S.1    Frickel, C.2    Wolfrom, C.3
  • 8
    • 0019945826 scopus 로고
    • The protein binding and elimination of methotrexate after intravenous infusions in cancer patients
    • Paxton JW. The protein binding and elimination of methotrexate after intravenous infusions in cancer patients. Clin Exp Pharmacol Physiol 1982; 9: 225-34.
    • (1982) Clin Exp Pharmacol Physiol , vol.9 , pp. 225-234
    • Paxton, J.W.1
  • 10
    • 0021324076 scopus 로고
    • Interaction of probenicid with the protein binding of methotrexate
    • Paxton JW. Interaction of probenicid with the protein binding of methotrexate. Pharmacology 1984; 28: 86-9.
    • (1984) Pharmacology , vol.28 , pp. 86-89
    • Paxton, J.W.1
  • 11
    • 0019433763 scopus 로고
    • Protein binding of methotrexate in sera from normal human beings: Effect of drug-concentration, pH, temperature, and storage
    • Paxton JW. Protein binding of methotrexate in sera from normal human beings: effect of drug-concentration, pH, temperature, and storage. J Pharmacol Methods 1981; 5: 203-13.
    • (1981) J Pharmacol Methods , vol.5 , pp. 203-213
    • Paxton, J.W.1
  • 12
    • 0017411650 scopus 로고
    • Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding
    • Taylor JR, Halprin KM. Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding. Arch Dermatol 1977; 113: 588-91.
    • (1977) Arch Dermatol , vol.113 , pp. 588-591
    • Taylor, J.R.1    Halprin, K.M.2
  • 13
    • 0021952899 scopus 로고
    • Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenicid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro
    • Gewirtz DA, Holt SA. Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenicid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro. Biochem Pharmacol 1985; 34: 747-54.
    • (1985) Biochem Pharmacol , vol.34 , pp. 747-754
    • Gewirtz, D.A.1    Holt, S.A.2
  • 14
    • 0018888518 scopus 로고
    • Modification of human serum albumin binding of methotrexate by folinic acid and certain drugs used in cancer chemotherapy
    • Coassolo P, Valentin M, Bourdeaux M, Briand C. Modification of human serum albumin binding of methotrexate by folinic acid and certain drugs used in cancer chemotherapy. Eur J Clin Pharmacol 1980; 17: 123-7.
    • (1980) Eur J Clin Pharmacol , vol.17 , pp. 123-127
    • Coassolo, P.1    Valentin, M.2    Bourdeaux, M.3    Briand, C.4
  • 15
    • 0016872250 scopus 로고
    • Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high dose methotrexate-folinic acid rescue protocols
    • Goldman ID, Gupta V, Courtland JW, Lotfield S. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high dose methotrexate-folinic acid rescue protocols. Cancer Res 1976; 36: 276-9.
    • (1976) Cancer Res , vol.36 , pp. 276-279
    • Goldman, I.D.1    Gupta, V.2    Courtland, J.W.3    Lotfield, S.4
  • 16
    • 0026514714 scopus 로고
    • Factors affecting in vitro protein binding of etoposide in humans
    • Fleming RA, Evans WE, Arbuck SG, Stewart CT. Factors affecting in vitro protein binding of etoposide in humans. J Pharm Sci 1992; 81: 259-64.
    • (1992) J Pharm Sci , vol.81 , pp. 259-264
    • Fleming, R.A.1    Evans, W.E.2    Arbuck, S.G.3    Stewart, C.T.4
  • 17
    • 0025169552 scopus 로고
    • Changes in renal clearance of total and unbound etoposide in patients with liver dysfunction
    • Stewart CT, Arbuck SG, Fleming RA, Evans WE. Changes in renal clearance of total and unbound etoposide in patients with liver dysfunction. J Clin Oncol 1990; 8: 1874-9.
    • (1990) J Clin Oncol , vol.8 , pp. 1874-1879
    • Stewart, C.T.1    Arbuck, S.G.2    Fleming, R.A.3    Evans, W.E.4
  • 18
    • 0025119417 scopus 로고
    • Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients
    • Stewart CT, Fleming RA, Arbuck SG, Evans WE. Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients. Cancer Res 1990; 50: 6854-6.
    • (1990) Cancer Res , vol.50 , pp. 6854-6856
    • Stewart, C.T.1    Fleming, R.A.2    Arbuck, S.G.3    Evans, W.E.4
  • 20
    • 15144349405 scopus 로고
    • In vitro and in vivo studies on the protein binding of teniposide (VM-26)
    • Borsi JD, Petros WP, Rodman JH, Evans WE. In vitro and in vivo studies on the protein binding of teniposide (VM-26). Med Pediatr Oncol 1990; 18: 127.
    • (1990) Med Pediatr Oncol , vol.18 , pp. 127
    • Borsi, J.D.1    Petros, W.P.2    Rodman, J.H.3    Evans, W.E.4
  • 21
    • 0018104544 scopus 로고
    • Comparison of uptake and binding of two epipodofillotoxin glucopyranosides, 4′-demethyl epipodofillotoxin thenylidene-beta-D-glucoside and 4-demethyl epidofillotoxin ethylene-beta-D-glucoside, in the L1210 leukemia cell
    • Allen LM. Comparison of uptake and binding of two epipodofillotoxin glucopyranosides, 4′-demethyl epipodofillotoxin thenylidene-beta-D-glucoside and 4-demethyl epidofillotoxin ethylene-beta-D-glucoside, in the L1210 leukemia cell. Cancer Res 1978; 38: 2549-54.
    • (1978) Cancer Res , vol.38 , pp. 2549-2554
    • Allen, L.M.1
  • 22
    • 0020035648 scopus 로고
    • Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
    • Allen LM, Tejada F, Okonmah AD, Nordqvist S. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale? Cancer Chemother Pharmacol 1982; 7: 151-6.
    • (1982) Cancer Chemother Pharmacol , vol.7 , pp. 151-156
    • Allen, L.M.1    Tejada, F.2    Okonmah, A.D.3    Nordqvist, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.